These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
391 related items for PubMed ID: 17598818
1. Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction. Norata GD, Ongari M, Garlaschelli K, Tibolla G, Grigore L, Raselli S, Vettoretti S, Baragetti I, Noto D, Cefalù AB, Buccianti G, Averna M, Catapano AL. J Intern Med; 2007 Jul; 262(1):104-12. PubMed ID: 17598818 [Abstract] [Full Text] [Related]
2. Resistin in human colorectal cancer: increased expression independently of resistin promoter -420C > G genotype. Wågsater D, Mumtaz M, Lofgren S, Hugander A, Dimberg J. Cancer Invest; 2008 Dec; 26(10):1008-14. PubMed ID: 18798067 [Abstract] [Full Text] [Related]
4. Resistin gene 3'-untranslated region +62G-->A polymorphism is associated with hypertension but not diabetes mellitus type 2 in a German population. Gouni-Berthold I, Giannakidou E, Faust M, Kratzsch J, Berthold HK, Krone W. J Intern Med; 2005 Dec; 258(6):518-26. PubMed ID: 16313475 [Abstract] [Full Text] [Related]
5. Adiponectin and resistin gene polymorphisms in association with their respective adipokine levels. Lau CH, Muniandy S. Ann Hum Genet; 2011 May; 75(3):370-82. PubMed ID: 21323646 [Abstract] [Full Text] [Related]
9. Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. Chiappelli M, Tampieri C, Tumini E, Porcellini E, Caldarera CM, Nanni S, Branzi A, Lio D, Caruso M, Hoffmann E, Caruso C, Licastro F. Int J Immunogenet; 2005 Dec; 32(6):349-53. PubMed ID: 16313298 [Abstract] [Full Text] [Related]
11. Frequency of the G/G genotype of resistin single nucleotide polymorphism at -420 appears to be increased in younger-onset type 2 diabetes. Ochi M, Osawa H, Hirota Y, Hara K, Tabara Y, Tokuyama Y, Shimizu I, Kanatsuka A, Fujii Y, Ohashi J, Miki T, Nakamura N, Kadowaki T, Itakura M, Kasuga M, Makino H. Diabetes; 2007 Nov; 56(11):2834-8. PubMed ID: 17698599 [Abstract] [Full Text] [Related]
13. The G-308A promoter variant of the tumor necrosis factor-alpha gene is associated with hypertension in adolescents harboring the metabolic syndrome. Sookoian S, García SI, Gianotti TF, Dieuzeide G, González CD, Pirola CJ. Am J Hypertens; 2005 Oct; 18(10):1271-5. PubMed ID: 16202847 [Abstract] [Full Text] [Related]
14. Analysis of genetic variations in the resistin gene shows no associations with obesity in women. Beckers S, Peeters AV, Freitas Fd, Mertens IL, Hendrickx JJ, Van Gaal LF, Van Hul W. Obesity (Silver Spring); 2008 Apr; 16(4):905-7. PubMed ID: 18239575 [Abstract] [Full Text] [Related]
16. Resistin polymorphisms are associated with cerebrovascular disease in Finnish Type 2 diabetic patients. Kunnari A, Ukkola O, Kesäniemi YA. Diabet Med; 2005 May; 22(5):583-9. PubMed ID: 15842513 [Abstract] [Full Text] [Related]
18. Synergistic effect of thrombomodulin promoter -33G/A polymorphism and smoking on the onset of acute myocardial infarction. Li YH, Chen JH, Tsai WC, Chao TH, Guo HR, Tsai LM, Wu HL, Shi GY. Thromb Haemost; 2002 Jan; 87(1):86-91. PubMed ID: 11848462 [Abstract] [Full Text] [Related]
19. [Study on the association of -689C/T polymorphism in the PPARgamma2 promoter with myocardial infarction]. Li JP, Cheng LX, He MA, Wu TC. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):19-22. PubMed ID: 18247297 [Abstract] [Full Text] [Related]